CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $7.14M invested in Chemomab Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 0.23% → 0.4% (+0.16%)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.27M | |
| 3 | +$620K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$62.7K |
| 5 |
HF
HRT Financial
New York
|
+$21K |
Top Sellers
| 1 | -$785K | |
| 2 | -$57.4K | |
| 3 | -$22.3K | |
| 4 |
Two Sigma Advisers
New York
|
-$16.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$10.8K |